Hanneke M. J. Nijland
Wageningen University & Research(NL)
Publications by Year
Research Areas
Pneumocystis jirovecii pneumonia detection and treatment, Tuberculosis Research and Epidemiology, HIV/AIDS drug development and treatment, Antibiotics Pharmacokinetics and Efficacy, Antibiotic Resistance in Bacteria
Most-Cited Works
- → Exposure to Rifampicin Is Strongly Reduced in Patients with Tuberculosis and Type 2 Diabetes(2006)239 cited
- → Pharmacokinetics and Tolerability of a Higher Rifampin Dose versus the Standard Dose in Pulmonary Tuberculosis Patients(2007)179 cited
- → Rifampicin Reduces Plasma Concentrations of Moxifloxacin in Patients with Tuberculosis(2007)170 cited
- → Pharmacokinetics of Antituberculosis Drugs in Pulmonary Tuberculosis Patients with Type 2 Diabetes(2009)122 cited
- → High incidence of adverse events in healthy volunteers receiving rifampicin and adjusted doses of lopinavir/ritonavir tablets(2008)112 cited
- → Clinical experience with the combined use of lopinavir/ritonavir and rifampicin(2009)48 cited
- → Evaluation of High- versus Standard-Dose Rifampin in Indonesian Patients with Pulmonary Tuberculosis(2006)28 cited
- → Reply to Gadkowski and Stout(2007)2 cited
- → Wageningen Dialogue : Hands-on navigator to explore why, when and how to engage with dialogue in research for more impact in society(2021)